Related Experiment Videos
Bcr interferes with beta-catenin-Tcf1 interaction.
Angelika Ress1, Karin Moelling
1Institute of Medical Virology, University of Zurich, Gloriastrasse 30, CH-8006 Zurich, Switzerland.
FEBS Letters
|January 31, 2006
Summary
The Bcr protein disrupts the Tcf1/beta-catenin complex, a key Wnt pathway component, through direct binding and phosphorylation-dependent dissociation. This reveals novel regulatory mechanisms for beta-catenin-mediated transcription in cancer progression.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Cancer Research
Background:
- The beta-catenin/Tcf complex is a crucial downstream effector of the Wnt signaling pathway, regulating gene expression involved in proliferation and tumor progression.
- Tcf1, when complexed with beta-catenin, activates beta-catenin-dependent gene expression, playing a significant role in cellular processes.
Purpose of the Study:
- To investigate the interaction between the Bcr protein and the Tcf1 transcription factor.
- To elucidate the mechanisms by which Bcr influences the Tcf1/beta-catenin complex and its transcriptional activity.
Main Methods:
- Co-immunoprecipitation assays to demonstrate binding between Bcr and Tcf1.
- In vitro kinase assays to study the effect of pp60(src) phosphorylation on the Bcr/Tcf1 complex.
Main Results:
- Expressed Bcr directly binds to the transcription factor Tcf1, disrupting the Tcf1/beta-catenin complex.
- Phosphorylation of Bcr by pp60(src) tyrosine kinase leads to the dissociation of the transcriptionally inactive Bcr/Tcf1 complex.
Conclusions:
- Bcr regulates Tcf/beta-catenin-mediated transcription through two distinct mechanisms: binding to beta-catenin and binding to Tcf1.
- These findings provide new insights into the regulation of Wnt signaling by Bcr, with implications for understanding tumor progression.